(RTX) Raytheon Technologies - Overview
Stock: Aircraft Engines, Avionics, Cabin Interiors, Defense Systems, Missiles
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.86% |
| Yield on Cost 5y | 4.13% |
| Yield CAGR 5y | 7.42% |
| Payout Consistency | 98.7% |
| Payout Ratio | 47.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.8% |
| Relative Tail Risk | -18.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.65 |
| Alpha | 45.99 |
| Character TTM | |
|---|---|
| Beta | 0.570 |
| Beta Downside | 0.784 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.84% |
| CAGR/Max DD | 0.87 |
Description: RTX Raytheon Technologies January 26, 2026
RTX Corporation (NYSE:RTX) is a diversified aerospace and defense firm that serves commercial, military, and government customers worldwide through three operating segments: Collins Aerospace, Pratt & Whitney, and Raytheon. The company, renamed from Raytheon Technologies in July 2023, traces its roots to 1934 and is headquartered in Arlington, Virginia.
Collins Aerospace delivers a broad portfolio of aircraft systems-including cabin interiors, avionics, and simulation-training solutions-plus aftermarket services such as spare-parts logistics and fleet management. Pratt & Whitney designs, manufactures, and supports commercial and military engines as well as auxiliary power units, while the Raytheon segment focuses on threat detection, tracking, and mitigation technologies for defense and commercial markets.
Key recent metrics (Q2 2024): consolidated revenue $18.6 billion (+5% YoY), with Collins Aerospace posting a 7% segment revenue growth driven by a 12% increase in aftermarket services; Pratt & Whitney’s engine backlog reached a record $45 billion, reflecting strong demand for fuel-efficient engines amid airline capacity expansion; and Raytheon’s defense contracts grew 9% YoY, supported by rising U.S. defense spending (projected FY 2025 budget increase of 3.2%). The broader aerospace sector is benefitting from a 4% annual rise in global commercial aircraft deliveries and a 2.5% CAGR in defense R&D outlays, both of which underpin RTX’s growth outlook.
For deeper valuation insights, see ValueRay’s RTX analysis.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 6.73b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 2.13 > 1.0 |
| NWC/Revenue: 1.75% < 20% (prev -0.45%; Δ 2.20% < -1%) |
| CFO/TA 0.06 > 3% & CFO 10.57b > Net Income 6.73b |
| Net Debt (33.67b) to EBITDA (14.98b): 2.25 < 3 |
| Current Ratio: 1.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.36b) vs 12m ago 0.95% < -2% |
| Gross Margin: 20.08% > 18% (prev 0.19%; Δ 1989 % > 0.5%) |
| Asset Turnover: 53.07% > 50% (prev 49.57%; Δ 3.49% > 0%) |
| Interest Coverage Ratio: 5.79 > 6 (EBITDA TTM 14.98b / Interest Expense TTM 1.83b) |
Altman Z'' 2.50
| A: 0.01 (Total Current Assets 60.33b - Total Current Liabilities 58.78b) / Total Assets 171.08b |
| B: 0.33 (Retained Earnings 56.72b / Total Assets 171.08b) |
| C: 0.06 (EBIT TTM 10.60b / Avg Total Assets 166.97b) |
| D: 0.89 (Book Value of Equity 92.13b / Total Liabilities 103.94b) |
| Altman-Z'' Score: 2.50 = A |
Beneish M -3.45
| DSRI: 0.52 (Receivables 14.70b/25.55b, Revenue 88.60b/80.74b) |
| GMI: 0.95 (GM 20.08% / 19.09%) |
| AQI: 0.93 (AQ_t 0.54 / AQ_t-1 0.58) |
| SGI: 1.10 (Revenue 88.60b / 80.74b) |
| TATA: -0.02 (NI 6.73b - CFO 10.57b) / TA 171.08b) |
| Beneish M-Score: -3.45 (Cap -4..+1) = AA |
What is the price of RTX shares?
Over the past week, the price has changed by -1.13%, over one month by +4.34%, over three months by +13.90% and over the past year by +57.14%.
Is RTX a buy, sell or hold?
- StrongBuy: 12
- Buy: 4
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RTX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 214.1 | 7.8% |
| Analysts Target Price | 214.1 | 7.8% |
| ValueRay Target Price | 262 | 31.9% |
RTX Fundamental Data Overview February 07, 2026
P/E Forward = 28.9017
P/S = 2.9655
P/B = 4.043
P/EG = 2.7555
Revenue TTM = 88.60b USD
EBIT TTM = 10.60b USD
EBITDA TTM = 14.98b USD
Long Term Debt = 34.29b USD (from longTermDebt, last quarter)
Short Term Debt = 3.62b USD (from shortTermDebt, last quarter)
Debt = 41.11b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 33.67b USD (from netDebt column, last quarter)
Enterprise Value = 296.42b USD (262.75b + Debt 41.11b - CCE 7.43b)
Interest Coverage Ratio = 5.79 (Ebit TTM 10.60b / Interest Expense TTM 1.83b)
EV/FCF = 37.33x (Enterprise Value 296.42b / FCF TTM 7.94b)
FCF Yield = 2.68% (FCF TTM 7.94b / Enterprise Value 296.42b)
FCF Margin = 8.96% (FCF TTM 7.94b / Revenue TTM 88.60b)
Net Margin = 7.60% (Net Income TTM 6.73b / Revenue TTM 88.60b)
Gross Margin = 20.08% ((Revenue TTM 88.60b - Cost of Revenue TTM 70.81b) / Revenue TTM)
Gross Margin QoQ = 19.46% (prev 20.38%)
Tobins Q-Ratio = 1.73 (Enterprise Value 296.42b / Total Assets 171.08b)
Interest Expense / Debt = 0.97% (Interest Expense 400.0m / Debt 41.11b)
Taxrate = 25.42% (584.0m / 2.30b)
NOPAT = 7.90b (EBIT 10.60b * (1 - 25.42%))
Current Ratio = 1.03 (Total Current Assets 60.33b / Total Current Liabilities 58.78b)
Debt / Equity = 0.63 (Debt 41.11b / totalStockholderEquity, last quarter 65.25b)
Debt / EBITDA = 2.25 (Net Debt 33.67b / EBITDA 14.98b)
Debt / FCF = 4.24 (Net Debt 33.67b / FCF TTM 7.94b)
Total Stockholder Equity = 63.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.03% (Net Income 6.73b / Total Assets 171.08b)
RoE = 10.62% (Net Income TTM 6.73b / Total Stockholder Equity 63.42b)
RoCE = 10.85% (EBIT 10.60b / Capital Employed (Equity 63.42b + L.T.Debt 34.29b))
RoIC = 7.63% (NOPAT 7.90b / Invested Capital 103.59b)
WACC = 7.03% (E(262.75b)/V(303.86b) * Re(8.02%) + D(41.11b)/V(303.86b) * Rd(0.97%) * (1-Tc(0.25)))
Discount Rate = 8.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 81.40% ; FCFF base≈6.40b ; Y1≈6.22b ; Y5≈6.22b
Fair Price DCF = 75.90 (EV 135.44b - Net Debt 33.67b = Equity 101.77b / Shares 1.34b; r=7.03% [WACC]; 5y FCF grow -3.91% → 2.90% )
EPS Correlation: 58.06 | EPS CAGR: 0.92% | SUE: 0.38 | # QB: 0
Revenue Correlation: 81.65 | Revenue CAGR: 12.25% | SUE: 0.69 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.50 | Chg30d=-0.014 | Revisions Net=+0 | Analysts=18
EPS current Year (2026-12-31): EPS=6.80 | Chg30d=+0.053 | Revisions Net=+2 | Growth EPS=+8.1% | Growth Revenue=+5.3%
EPS next Year (2027-12-31): EPS=7.50 | Chg30d=+0.012 | Revisions Net=+0 | Growth EPS=+10.3% | Growth Revenue=+6.4%